James S. Scibetta, SVP, Chief Financial Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 15,000 shares at $112.91 ($1.7M) on 2015-02-06, disclosed to the SEC on 2015-02-09.
Scheduled sale ($1.7M) by SVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.17 | 4,293 | $473K | 28.3% |
| 2 | $111.11 | 5,904 | $656K | 39.3% |
| 3 | $111.98 | 3,103 | $347K | 20.8% |
| 4 | $112.91 | 1,700 | $192K | 11.5% |
| Total | $111.22 avg | 15,000 | $1.7M | 100% |
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |